Hexagon Nutrition IPO Sees Retail Surge as RII Segment Books Over 4x Demand Amid QIB Silence

Hexagon Nutrition IPO Sees Retail Surge as RII Segment Books Over 4x Demand Amid QIB Silence​

Hexagon Nutrition's initial public offering (IPO) saw strong performance on the second day of bidding, driven primarily by robust interest from retail and non-institutional investors. The issue, which is an offer for sale (OFS), was subscribed at 2.92 times by 11:48 am on Monday, indicating healthy demand from individual and specific investor segments.

The IPO generated significant buzz following a solid opening day, having achieved full subscription early on June 5. The offering provides investors with the opportunity to participate in the sale of equity shares through this public issue.

Detailed Subscription Metrics Reveal Market Dynamics​

As per cumulative data from NSE and BSE, the IPO garnered bids for 6.31 crore shares against an offering of 2.16 crore shares. This demand demonstrates substantial interest across various investor categories.

The retail individual investor (RII) portion showed particular strength, attracting a subscription rate of 4.23 times. Similarly, non-institutional investors (NII) were enthusiastically receptive, with their category booked at 3.74 times the allocated shares.

QIB Participation Remains Weak As Demand Shifts​

A notable contrast emerged in the Qualified Institutional Buyer (QIB) segment. The institutional buyers remained largely on the sidelines during the bidding process. The QIB category was subscribed only 0.02 times as of the latest reporting update, suggesting limited interest from large financial institutions.

Within the NII segment, smaller investors demonstrated significant enthusiasm, with the small NII portion attracting bids for 6.26 times its reserved shares. The bigger NII category followed suit, achieving a subscription rate of 2.48 times.

Understanding the Hexagon Nutrition Offering Mechanics​

The public issue is structured entirely as an offer for sale (OFS) amounting to Rs 139 crore. This means the company itself will not receive any proceeds from the IPO; instead, the sale proceeds are allocated directly to the selling shareholders.

The fixed price band set for the shares ranges between Rs 42 and Rs 45 per share. Investors who wish to participate can apply for a minimum lot size of 333 shares, equating to a minimum investment of Rs 14,985 at the upper end of the price band.

IPO Timeline and Listing Details​

Hexagon Nutrition opened its subscription process on June 5, with the bidding period concluding on June 9. Investors are advised that the allotment of shares is scheduled for finalization on June 10. Refunds are expected to be initiated on June 11, with successful applicants' shares likely credited to their demat accounts the same day. The stock is slated to list on both the NSE and BSE on June 12.

Company Background and Strategic Listing Rationale​

Founded in 1993, Hexagon Nutrition initially specialized in micronutrient formulations before expanding into a diversified portfolio of branded nutrition products. The company maintains a global footprint across 75 countries.

Through brands like Pentasure, Obesigo, and Pediagold, the organization provides a wide range of products spanning health, wellness, and clinical nutrition segments. Hexagon Nutrition stated that the proposed listing aims to enhance its brand recognition and visibility while providing liquidity to existing shareholders.

Anchor Investor Mandate and Next Steps​

Prior to the IPO opening, Hexagon Nutrition successfully raised Rs 41.66 crore from anchor investors, securing preliminary financial backing before the general public launch. The successful conclusion of this offering marks a significant step in strengthening the company's financial profile amidst its international operations.